MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
GRCE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Grace Therapeutics (GRCE) Ownership - Who owns Grace Therapeutics?

Grace Therapeutics Inc is a late-stage biopharma company with drug candidates addressing rare and orphan diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Other
Address
103 Carnegie Center
Phone
+1 609 322-1602
Employees
5
Web
https://www.gracetx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
44.6M
P/E Ratio
N/A
Total Cash
13.76M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
-0.58
Dividend Yield
N/A
Total Cash/Share
0.65
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
GRCE
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI-Driven Trading for GRCE
A.I. Advisor
published General Information

General Information

a manufacturer of Pharmaceutical products

Industry Biotechnology

Industry
Pharmaceuticals Other
Address
103 Carnegie Center
Phone
+1 609 322-1602
Employees
5
Web
https://www.gracetx.com
Who owns Grace Therapeutics? GRCE symbol Ownership - Tickeron.com